Silo Pharma Stock Price Patterns
| SILO Stock | USD 0.31 0.01 3.13% |
Momentum 39
Sell Extended
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate trading signals. We use our internally-built news screening methodology to estimate the value of Silo Pharma based on different types of headlines from major news networks to social media. Using Silo Pharma hype-based prediction, you can estimate the value of Silo Pharma from the perspective of Silo Pharma response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Silo Pharma. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Silo Pharma to buy its otc stock at a price that has no basis in reality. In that case, they are not buying Silo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Silo Pharma after-hype prediction price | USD 0.35 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Silo |
Silo Pharma After-Hype Price Density Analysis
As far as predicting the price of Silo Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Silo Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Silo Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Silo Pharma Estimiated After-Hype Price Volatility
In the context of predicting Silo Pharma's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Silo Pharma's historical news coverage. Silo Pharma's after-hype downside and upside margins for the prediction period are 0.02 and 5.19, respectively. We have considered Silo Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Silo Pharma is out of control at this time. Analysis and calculation of next after-hype price of Silo Pharma is based on 3 months time horizon.
Silo Pharma OTC Stock Price Outlook Analysis
Have you ever been surprised when a price of a OTC Stock such as Silo Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Silo Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Silo Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.54 | 4.84 | 0.62 | 0.83 | 17 Events / Month | 4 Events / Month | In about 17 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.31 | 0.35 | 11.85 |
|
Silo Pharma Hype Timeline
Silo Pharma is at this time traded for 0.31. The entity has historical hype elasticity of -0.62, and average elasticity to hype of competition of -0.83. Silo is expected to increase in value after the next headline, with the price projected to jump to 0.35 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 11.85%, whereas the daily expected return is at this time at -0.54%. The volatility of related hype on Silo Pharma is about 313.07%, with the expected price after the next announcement by competition of -0.52. The company has a current ratio of 32.61, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Silo Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, Silo Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Silo Pharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Silo to invest in growth at high rates of return. When we think about Silo Pharma's use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next expected press release will be in about 17 days. Check out Silo Pharma Basic Forecasting Models to cross-verify your projections.Silo Pharma Related Hype Analysis
Having access to credible news sources related to Silo Pharma's direct competition is more important than ever and may enhance your ability to predict Silo Pharma's future price movements. Getting to know how Silo Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Silo Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GILD | Gilead Sciences | (0.69) | 8 per month | 1.27 | 0.17 | 3.01 | (2.41) | 6.70 | |
| SNY | Sanofi ADR | (0.12) | 7 per month | 0.00 | (0.11) | 1.87 | (2.19) | 5.92 | |
| AMGN | Amgen Inc | (6.78) | 8 per month | 1.16 | 0.15 | 3.81 | (2.59) | 11.18 | |
| MRK | Merck Company | 1.01 | 7 per month | 1.07 | 0.26 | 3.59 | (1.98) | 8.09 | |
| NVO | Novo Nordisk AS | (1.15) | 8 per month | 0.00 | (0.03) | 5.80 | (4.07) | 23.77 |
Silo Pharma Additional Predictive Modules
Most predictive techniques to examine Silo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Silo using various technical indicators. When you analyze Silo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Silo Pharma Predictive Indicators
The successful prediction of Silo Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Silo Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Silo Pharma based on analysis of Silo Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Silo Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Silo Pharma's related companies.
Pair Trading with Silo Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Silo Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silo Pharma will appreciate offsetting losses from the drop in the long position's value.Moving together with Silo OTC Stock
Moving against Silo OTC Stock
| 0.86 | GPOVF | Grupo Carso SAB | PairCorr |
| 0.81 | MRK | Merck Company Aggressive Push | PairCorr |
| 0.78 | JNJ | Johnson Johnson | PairCorr |
| 0.73 | DD | Dupont De Nemours Earnings Call This Week | PairCorr |
| 0.72 | AA | Alcoa Corp | PairCorr |
| 0.71 | XOM | Exxon Mobil Corp Aggressive Push | PairCorr |
The ability to find closely correlated positions to Silo Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Silo Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Silo Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Silo Pharma to buy it.
The correlation of Silo Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Silo Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Silo Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Silo Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Silo OTC Stock
Silo Pharma financial ratios help investors to determine whether Silo OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Silo with respect to the benefits of owning Silo Pharma security.